产品浏览
-
- DNA & RNA (46)
- siRNA/Chimera (15364)
- Proteins/Peptides (25865)
- MaxPab® Ab (16217)
- Monoclonal Ab (21396)
- Polyclonal Ab (27483)
- Conjugate Ab/Beads (1328)
- Secondary/Tag Ab (1005)
- Lysates/Slides (9167)
- Ab Pairs/Kits (7698)
- Ab Array Det Kits (1)
- Ab Concentration Kits (1)
- Ab Labeling Kits (40)
- Ab Pairs for ELISA (1352)
- Ab Pairs for IP-WB (2015)
- Ab Pairs for PP (259)
- Ab Pairs for PPI (606)
- Ab Purification Kits (3)
- Assay Kits (521)
- Cell-Based ELISA Kits (708)
- CLIA Kits (44)
- ELISA Kits (2113)
- IHC Kits (6)
- IP & ChIP Kits (20)
- Mutation Detection Kits (3)
- Protein Expression Kits (6)
- Ab & Tissue Arrays (128)
- IHC/Pathology Ab (17916)
- In Situ Hybridization (1056)
- Circulating Tumor Cell (29)
- Systems (4)
- ASR/IVDiagnostics (21)
- Related Product Showcase
- By Pathway
- By Disease
 |
 |
Click this icon to add products to compare list. Select up to 10 products.
- Home > Products > Monoclonal Ab > Human > Binding > Others > APOA5 monoclonal antibody, clone 4H8H8E2
APOA5 monoclonal antibody, clone 4H8H8E2
- 目录号 # : MAB2375
- 访问频率 :
- 尺寸
- 价格
- 库存
- 可得性
- 购物车
- 100 uL
- USD $ 415
- order now, ship in 5 days
-
-
- 该价格仅在China有效。请选择国家。
- 询问我们任何问题
- 付款信息
信用卡 :
Email : sales@abnova.com
Phone : +886-2-87511888
Fax : +886-2-87511166- 产品会直接装运至客户处。
- Specification
- Product Description:
- Mouse monoclonal antibody raised against full length recombinant APOA5.
- Immunogen:
- Recombinant protein corresponding to full length human APOA5.
- Host:
- Mouse
- Reactivity:
- Human
- Form:
- Liquid
- Isotype:
- IgG1, kappa
- Quality Control Testing:
- Antibody Reactive Against Recombinant Protein.
- Recommend Usage:
- The optimal working dilution should be determined by the end user.
- Storage Buffer:
- In PBS (0.1% sodium azide)
- Storage Instruction:
- Store at -20°C or -80°C.
Aliquot to avoid repeated freezing and thawing.
- Note:
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Publication Reference
- 1.
- The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins.
O'Brien PJ, Alborn WE, Sloan JH, Ulmer M, Boodhoo A, Knierman MD, Schultze AE, Konrad RJ.Clin Chem. 2005 Feb;51(2):351-9. Epub 2004 Nov 4.
- 2.
- The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-alpha and contains a novel farnesoid X-activated receptor response element.
Prieur X, Coste H, Rodriguez JC.J Biol Chem. 2003 Jul 11;278(28):25468-80. Epub 2003 Apr 22.
- 3.
- An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing.
Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, Krauss RM, Rubin EM.Science. 2001 Oct 5;294(5540):169-73.
- Application Image
- ELISA
- Entrez GeneID:
- 116519
- Gene Name:
- APOA5
- Gene Alias:
- APOA-V,APOAV,MGC126836,MGC126838,RAP3
- Gene Description:
- apolipoprotein A-V
- Gene Ontology:
- Hyperlink
- Gene Summary:
- The protein encoded by this gene is an apolipoprotein and an important determinant of plasma triglyceride levels, a major risk factor for coronary artery disease. It is a component of high density lipoprotein and is highly similar to a rat protein that is upregulated in response to liver injury. This gene uses alternate polyadenylation sites and is located proximal to the apolipoprotein gene cluster on chromosome 11q23. [provided by RefSeq
- Other Designations:
- apolipoprotein A-V precursor variant 1,apolipoprotein A-V precursor variant 2,apolipoprotein A5,apolipoprotein AV,regeneration-associated protein 3
- Gene Pathway
- Related Disease
- Acute Disease
- Alzheimer Disease
- Alzheimer disease
- Aortic Diseases
- Arteriosclerosis
- Atherosclerosis
- Atherosclerosis
- Brain Ischemia
- Calcinosis
- Cardiovascular Diseases
- Carotid Artery Diseases
- Carotid Stenosis
- Cerebral Infarction
- Cerebrovascular Accident
- Cleft Lip
- Cleft Palate
- Coronary Artery Disease
- Coronary Disease
- Diabetes Complications
